These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 14499198)
21. Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying. Quaglia F; De Rosa G; Granata E; Ungaro F; Fattal E; Immacolata La Rotonda M J Control Release; 2003 Jan; 86(2-3):267-78. PubMed ID: 12526823 [TBL] [Abstract][Full Text] [Related]
22. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres. Ravivarapu HB; Burton K; DeLuca PP Eur J Pharm Biopharm; 2000 Sep; 50(2):263-70. PubMed ID: 10962237 [TBL] [Abstract][Full Text] [Related]
23. Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles. Singh M; Shirley B; Bajwa K; Samara E; Hora M; O'Hagan D J Control Release; 2001 Jan; 70(1-2):21-8. PubMed ID: 11166404 [TBL] [Abstract][Full Text] [Related]
24. Loading of plasmid DNA into PLGA microparticles using TROMS (Total Recirculation One-Machine System): evaluation of its integrity and controlled release properties. del Barrio GG; Novo FJ; Irache JM J Control Release; 2003 Jan; 86(1):123-30. PubMed ID: 12490378 [TBL] [Abstract][Full Text] [Related]
25. In vitro controlled release kinetics of local anaesthetics from poly(D,L-lactide) and poly(lactide-co-glycolide) microspheres. Le Corre P; Rytting JH; Gajan V; Chevanne F; Le Verge R J Microencapsul; 1997; 14(2):243-55. PubMed ID: 9132474 [TBL] [Abstract][Full Text] [Related]
26. Biodegradable microparticles for sustained release of a new GnRH antagonist--part I: Screening commercial PLGA and formulation technologies. Schwach G; Oudry N; Delhomme S; Lück M; Lindner H; Gurny R Eur J Pharm Biopharm; 2003 Nov; 56(3):327-36. PubMed ID: 14602174 [TBL] [Abstract][Full Text] [Related]
27. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres. Yang Y; Gao Y; Mei X Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467 [TBL] [Abstract][Full Text] [Related]
28. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination. Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180 [TBL] [Abstract][Full Text] [Related]
29. An investigation into the effects of residual water on the glass transition temperature of polylactide microspheres using modulated temperature DSC. Passerini N; Craig DQ J Control Release; 2001 May; 73(1):111-5. PubMed ID: 11337064 [TBL] [Abstract][Full Text] [Related]
30. Encapsulation of immunoglobulin G by solid-in-oil-in-water: effect of process parameters on microsphere properties. Marquette S; Peerboom C; Yates A; Denis L; Goole J; Amighi K Eur J Pharm Biopharm; 2014 Apr; 86(3):393-403. PubMed ID: 24184674 [TBL] [Abstract][Full Text] [Related]
31. Poly(lactic-co-glycolic acid) microspheres for the controlled release of huperzine A: in vitro and in vivo studies and the application in the treatment of the impaired memory of mice. Chu D; Tian J; Liu W; Li Z; Li Y Chem Pharm Bull (Tokyo); 2007 Apr; 55(4):625-8. PubMed ID: 17409558 [TBL] [Abstract][Full Text] [Related]
32. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles. Panyam J; Dali MM; Sahoo SK; Ma W; Chakravarthi SS; Amidon GL; Levy RJ; Labhasetwar V J Control Release; 2003 Sep; 92(1-2):173-87. PubMed ID: 14499195 [TBL] [Abstract][Full Text] [Related]
33. The fate of biodegradable microspheres injected into rat brain. Nicholas AP; McInnis C; Gupta KB; Snow WW; Love DF; Mason DW; Ferrell TM; Staas JK; Tice TR Neurosci Lett; 2002 Apr; 323(2):85-8. PubMed ID: 11950499 [TBL] [Abstract][Full Text] [Related]
34. Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres. Meinel L; Illi OE; Zapf J; Malfanti M; Peter Merkle H; Gander B J Control Release; 2001 Jan; 70(1-2):193-202. PubMed ID: 11166419 [TBL] [Abstract][Full Text] [Related]
35. Stabilization and encapsulation of human immunoglobulin G into biodegradable microspheres. Wang J; Chua KM; Wang CH J Colloid Interface Sci; 2004 Mar; 271(1):92-101. PubMed ID: 14757081 [TBL] [Abstract][Full Text] [Related]
36. Transfection of HEK cells via DNA-loaded PLGA and P(FASA) nanospheres. Sandor M; Mehta S; Harris J; Thanos C; Weston P; Marshall J; Mathiowitz E J Drug Target; 2002 Sep; 10(6):497-506. PubMed ID: 12575740 [TBL] [Abstract][Full Text] [Related]
37. Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit. Horisawa E; Hirota T; Kawazoe S; Yamada J; Yamamoto H; Takeuchi H; Kawashima Y Pharm Res; 2002 Apr; 19(4):403-10. PubMed ID: 12033371 [TBL] [Abstract][Full Text] [Related]
38. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies. Gavini E; Chetoni P; Cossu M; Alvarez MG; Saettone MF; Giunchedi P Eur J Pharm Biopharm; 2004 Mar; 57(2):207-12. PubMed ID: 15018976 [TBL] [Abstract][Full Text] [Related]
39. Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres. Roullin VG; Deverre JR; Lemaire L; Hindré F; Venier-Julienne MC; Vienet R; Benoit JP Eur J Pharm Biopharm; 2002 May; 53(3):293-9. PubMed ID: 11976017 [TBL] [Abstract][Full Text] [Related]
40. Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. Tinsley-Bown AM; Fretwell R; Dowsett AB; Davis SL; Farrar GH J Control Release; 2000 May; 66(2-3):229-41. PubMed ID: 10742583 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]